| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |